Impetine®

Mupirocin, the active ingredient in Impetine®, is an antibiotic presented as a topical formulation for skin application. It inhibits bacterial protein synthesis and is used to treat superficial skin infections such as impetigo, infected eczema, and minor wounds, providing localized antibacterial activity in both children and adults.

GNH USA supplies Impetine® as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution aligned to EU regulatory standards and global procurement requirements.

Mupirocin is a topical antibacterial agent used to manage superficial bacterial skin infections.

Impetigo: eradicates Staphylococcus aureus and Streptococcus pyogenes causing characteristic lesions. Infected eczema: reduces bacterial colonisation and promotes healing of eczematous skin. Minor cuts and abrasions: prevents or treats secondary bacterial infection of superficial wounds. Nasal carriage of MRSA: applied intranasally to diminish colonisation and reduce transmission risk. Post‑surgical skin sites: controls bacterial growth on minor surgical incisions.

Mupirocin is generally well tolerated when applied to intact skin, but local reactions may occur.

Common Side Effects: - Itching at the application site - Burning sensation - Redness or erythema - Pain or tenderness - Dry or flaky skin - Local rash

Serious or Rare Side Effects: - Allergic reactions such as angioedema - Severe contact dermatitis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Anaphylaxis - Systemic infection from resistant organisms

When using Impetine®, consider the following safety measures.

Allergy assessment: avoid use in patients with known hypersensitivity to mupirocin or related antibiotics. Pregnancy and lactation: use only if the prescriber determines that benefits outweigh potential risks, as safety data are limited. Age considerations: safety in neonates and infants has not been fully established; apply with caution in young children. Extent of application: limit treatment to the prescribed area to minimise systemic absorption. Concurrent antibiotic therapy: monitor for reduced efficacy if combined with other topical agents. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mupirocin may interact with other topical or systemic agents; monitor patients accordingly.

Major Interactions (Avoid): - Other topical antibacterial agents: concurrent use may increase the risk of local irritation. - Topical corticosteroids: may diminish the antibacterial effect of mupirocin.

Moderate Interactions (Monitor Closely): - Systemic antibiotics: may alter normal bacterial flora and affect resistance patterns. - Antifungal creams: potential for mixed infection; assess clinical response. - Wound dressings containing silver: may affect mupirocin absorption and efficacy.